Dr. Katerina Johnson, who conducted her Ph.D. in the University's Department of Experimental Psychology, was researching the science of that 'gut feeling' - the relationship between the bacteria living in the gut (the gut microbiome) and behavioral traits. In a large human study she found that both gut microbiome composition and diversity were related to differences in personality, including sociability and neuroticism.
She said: "There has been growing research linking the gut microbiome to the brain and behavior, known as the microbiome-gut-brain axis. Most research has been conducted in animals, whilst studies in humans have focused on the role of the gut microbiome in neuropsychiatric conditions. In contrast, my key interest was to look in the general population to see how variation in the types of bacteria living in the gut may be related to personality."
Previous studies have linked the gut microbiome to autism (a condition characterized by impaired social behavior). Dr Johnson's study found that numerous types of bacteria that had been associated with autism in previous research were also related to differences in sociability in the general population. Katerina explained: "This suggests that the gut microbiome may contribute not only to the extreme behavioral traits seen in autism but also to variation in social behavior in the general population. However, since this is a cross-sectional study, future research may benefit from directly investigating the potential effect these bacteria may have on behavior, which may help inform the development of new therapies for autism and depression."
Another interesting finding related to social behavior was that people with larger social networks tended to have a more diverse gut microbiome, which is often associated with better gut health and general health.
This is the first study to find a link between sociability and microbiome diversity in humans and follows on from similar findings in primates which have shown that social interactions can promote gut microbiome diversity. This result suggests the same may also be true in human populations." Related Stories
Also in Industry News
How to decide whether or not to start treatment for prostate cancer?
Analysis of the SARS-CoV-2 proteome via visual tools
$65m investment increases British Patient Capital’s exposure to life sciences and health technology